ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development

Go back to ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development
Immucell Corp (NASDAQ: ICCC) Delayed: 11.04 -0.17 (1.52%)
Previous Close $11.21    52 Week High $8.29 
Open $11.33    52 Week Low $4.99 
Day High $11.33    P/E 138.00 
Day Low $10.99    EPS $0.08 
Volume 16,442